← Back to Screener
Gelteq Limited Ordinary Shares (GELS)
Price$0.50
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-61.91%
Price vs S&P 500 (4W)5.75%
VGM Score26.70
Market Capitalization$3.77M
All Metrics
Book Value / Share (Quarterly)$1.04
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)3.93%
Cash Flow / Share (Quarterly)$-0.41
Price vs S&P 500 (YTD)-46.03%
EPS (TTM)$-0.75
10-Day Avg Trading Volume0.04M
EPS Excl Extra (TTM)$-0.75
EPS (Annual)$-0.50
ROI (Annual)-33.19%
Gross Margin (Annual)30.34%
Cash / Share (Quarterly)$0.02
ROA (Last FY)-30.94%
EBITD / Share (TTM)$-0.44
ROE (5Y Avg)-20.64%
Cash Flow / Share (Annual)$-0.41
P/B Ratio0.48x
P/B Ratio (Quarterly)1.50x
Net Income / Employee (Annual)$-671,723
Net Interest Coverage (TTM)-3.62x
ROA (TTM)-42.71%
EPS Incl Extra (Annual)$-0.50
Current Ratio (Annual)0.27x
Quick Ratio (Quarterly)0.14x
3-Month Avg Trading Volume0.06M
52-Week Price Return-70.94%
Revenue / Employee (TTM)$16,768
P/S Ratio (Annual)45.62x
Asset Turnover (Annual)0.01x
52-Week High$3.51
EPS Excl Extra (Annual)$-0.50
26-Week Price Return-53.98%
Quick Ratio (Annual)0.14x
13-Week Price Return-37.09%
Total Debt / Equity (Annual)0.27x
Current Ratio (Quarterly)0.27x
Enterprise Value$8.09M
Revenue / Employee (Annual)$16,768
Pretax Margin (Annual)-4011.74%
Cash / Share (Annual)$0.02
3-Month Return Std Dev93.90%
Net Income / Employee (TTM)$-1,005,674
ROE (Last FY)-42.05%
Net Interest Coverage (Annual)-4.44x
EPS Basic Excl Extra (Annual)$-0.50
Total Debt / Equity (Quarterly)0.27x
EPS Incl Extra (TTM)$-0.75
Receivables Turnover (Annual)6.11x
ROI (TTM)-46.59%
Revenue / Share (Annual)$0.01
Price vs S&P 500 (52W)-95.30%
Year-to-Date Return-37.88%
5-Day Price Return2.52%
EPS Normalized (Annual)$-0.50
ROA (5Y Avg)-16.14%
Net Profit Margin (Annual)-4011.74%
Month-to-Date Return1.64%
EBITD / Share (Annual)$-0.28
Operating Margin (Annual)-3015.94%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-17.25%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-0.75
P/B Ratio (Annual)1.50x
Book Value / Share (Annual)$1.04
Price vs S&P 500 (13W)-45.34%
Beta0.96x
Revenue / Share (TTM)$0.01
ROE (TTM)-57.52%
52-Week Low$0.39
mGradeD
vgmGradeD
Show chart for
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
GELSGelteq Limited Ordinary Shares | — | — | D | $0.50 |
| LLYEli Lilly & Co. | D | B | B | $1131.42 |
| JNJJohnson & Johnson | D | C | B | $232.77 |
| ABBVABBVIE INC. | D | C | C | $227.23 |
| MRKMerck & Co., Inc. | C | C | B | $120.79 |
| NVSNovartis AG | C | C | C | $149.16 |
| AZNAstraZeneca PLC | D | B | C | $185.95 |
| NVONovo-Nordisk A/S | B | B | B | $42.96 |
| ABTAbbott Laboratories | C | C | D | $91.07 |
| PFEPfizer Inc. | B | C | C | $26.04 |
| BMYBristol-Myers Squibb Co. | B | C | B | $57.27 |
About
Gelteq Ltd develops proprietary gel-based delivery systems for prescription drugs, nutraceuticals, and pet care products. The company's patent-pending technology enables multi-ingredient dosage forms while preserving the efficacy and accessibility of oral delivery. The business model combines technology licensing to manufacturers with white label production services.